The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Ozerov S.S.

Dmitry Rogachev National Medical Research Center for Pediatric Hematology, Oncology and Immunology

Ryzhova M.V.

Burdenko Neurosurgical Center

Kumirova E.V.

Morozov Children’s City Clinical Hospital

Diffuse brainstem tumors in children. Tumor biology and hope for a better outcome. Current state of the problem

Authors:

Ozerov S.S., Ryzhova M.V., Kumirova E.V.

More about the authors

Journal: Burdenko's Journal of Neurosurgery. 2021;85(4): 77‑86

DOI: 10.17116/neiro20218504177

Read: 17421 times

Download PDF (RU)
Download PDF
Contact the author
Table of contents

DIFFUSE BRAINSTEM TUMORS IN CHILDREN. TUMOR BIOLOGY AND HOPE FOR A BETTER OUTCOME. CURRENT STATE OF THE PROBLEM
DIFFUSE BRAINSTEM TUMORS IN CHILDREN. TUMOR BIOLOGY AND HOPE FOR A BETTER OUTCOME. CURRENT STATE OF THE PROBLEM

To cite this article:

Ozerov SS, Ryzhova MV, Kumirova EV. Diffuse brainstem tumors in children. Tumor biology and hope for a better outcome. Current state of the problem. Burdenko's Journal of Neurosurgery. 2021;85(4):77‑86. (In Russ., In Engl.)
https://doi.org/10.17116/neiro20218504177

Подписка 2025 Журнал «Вопросы нейрохирургии» имени Н.Н. Бурденко (Burdenko's Journal of Neurosurgery)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
New pathogenic treatments for myasthenia gravis. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(1):31-38
Problems of pregnancy planning and gestation in patients with diffuse toxic goiter after radiotherapy. Russian Bulletin of Obstetrician-Gynecologist. 2025;(1):82-87
The choice of radiotherapy dose fractionation regi­men for grade 4 gliomas depe­nding on the status of MGMT. P.A. Herzen Journal of Onco­logy. 2025;(1):13-18
Radiation therapy with focal dose esca­lation in the treatment of glioblastoma. P.A. Herzen Journal of Onco­logy. 2025;(2):64-69
Clinical significance of gene­tic muta­tions in epithelial tumors of the thymus. P.A. Herzen Journal of Onco­logy. 2025;(2):70-75
Lean mana­gement example at the radiotherapy depa­rtment. Medi­cal Technologies. Asse­ssment and Choice. 2025;(2):67-73
A clinical case of fami­lial alopecia areata in combination with immune pathology. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(3):304-312
Meta­stasis of thyroid cancer to retroperitoneal lymph nodes and breast. P.A. Herzen Journal of Onco­logy. 2025;(4):82-85
Prevention and treatment of dermal toxi­city in children receiving anti-tumor radiation. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(4):470-480
Resu­lts of testing an antioxidant gel film for the prevention and treatment of palmar-plantar syndrome in cancer patients. P.A. Herzen Journal of Onco­logy. 2025;(5):59-63
Abstract:

Diffuse brainstem tumor is a fatal disease and the main cause of child mortality from neoplasms of central nervous system. So far, no effective therapy has been found for this disease. The authors discuss the modern aspects of clinical data, biology, diagnosis and treatment of patients with diffuse brainstem tumors.

Keywords:

brainstem tumors
brain tumor
radiotherapy
targeted therapy

Authors:

Ozerov S.S.

Dmitry Rogachev National Medical Research Center for Pediatric Hematology, Oncology and Immunology

Ryzhova M.V.

Burdenko Neurosurgical Center

Kumirova E.V.

Morozov Children’s City Clinical Hospital

Received:

20.05.2020

Accepted:

19.03.2021

Close metadata

References:

  1. Khuhlaeva EA, Konovalov AN, Pronin IN, Kornienko VN, Gavriushin AV. Neuroradiology and classification principles of brain stem tumors. Medicinskaya visualizacia. 2011;6:62-74. (In Russ.).
  2. Kornienko VN, Pronin IN. Diagnostic neuroradiology. Springer-Verlag, Berlin; 2009;680-705.  https://doi.org/10.1007/978-3-540-75653-8
  3. Veldhuijzen van Zanten SEM, Baugh J, Chaney B, De Jongh D, Sanchez Aliaga E, Barkhof F, Noltes J, De Wolf R, Van Dijk J, Cannarozzo A, Damen-Korbijn CM, Lieverst JA, Colditz N, Hoffmann M, Warmuth-Metz M, Bison B, Jones DTW, Sturm D, Gielen GH, Jones C, Hulleman E, Calmon R, Castel D, Varlet P, Giraud G, Slavc I, Van Gool S, Jacobs S, Jadrijevic-Cvrlje F, Sumerauer D, Nysom K, Pentikainen V, Kivivuori SM, Leblond P, Entz-Werle N, von Bueren AO, Kattamis A, Hargrave DR, Hauser P, Garami M, Thorarinsdottir HK, Pears J, Gandola L, Rutkauskiene G, Janssens GO, Torsvik IK, Perek-Polnik M, Gil-da-Costa MJ, Zheludkova O, Shats L, Deak L, Kitanovski L, Cruz O, Morales La Madrid A, Holm S, Gerber N, Kebudi R, Grundy R, Lopez-Aguilar E, Zapata-Tarres M, Emmerik J, Hayden T, Bailey S, Biassoni V, Massimino M, Grill J, Vandertop WP, Kaspers GJL, Fouladi M, Kramm CM, van Vuurden DG; members of the SIOPE DIPG Network. Development of the SIOPE DIPG network, registry and imaging repository: a collaborative effort to optimize research into a rare and lethal disease. Journal of Neuro-Oncology. 2017;132(2):255-266.  https://doi.org/10.1007/s11060-016-2363-y
  4. Caretti V, Bugiani M, Freret M, Schellen P, Jansen M, van Vuurden D, Kaspers G, Fisher PG, Hulleman E, Wesseling P, Vogel H, Monje M. Subventricular spread of diffuse intrinsic pontine glioma. Acta Neuropathologica. 2014;128(4):605-607.  https://doi.org/10.1007/s00401-014-1307-x.
  5. Vanan MI, Eisenstat DD. DIPG in Children — What Can We Learn from the Past? Frontiers in Oncology. 2015;5:237.  https://doi.org/10.3389/fonc.2015.00237
  6. Chiarelli PA, Chu JK, Krieger MD. Brainstem Tumors. In: Di Rocco C, Pang D, Rutka JT, eds. Textbook of Pediatric Neurosurgery. Cham: Springer International Publishing; 2019;1-35.  https://doi.org/10.1007/978-3-319-31512-6_89-1
  7. Hankinson TC, Campagna EJ, Foreman NK, Handler MH. Interpretation of magnetic resonance images in diffuse intrinsic pontine glioma: a survey of pediatric neurosurgeons. Journal of Neurosurgery. Pediatrics. 2011;8(1):97-102.  https://doi.org/10.3171/2011.4.PEDS1180
  8. Albright AL, Packer RJ, Zimmerman R, Rorke LB, Boyett J, Hammond GD. Magnetic resonance scans should replace biopsies for the diagnosis of diffuse brain stem gliomas: a report from the Children’s Cancer Group. Neurosurgery. 1993;33(6):1026-1030. https://doi.org/10.1227/00006123-199312000-00010
  9. Puget S, Beccaria K, Blauwblomme T, Roujeau T, James S, Grill J, Zerah M, Varlet P, Sainte-Rose C. Biopsy in a series of 130 pediatric diffuse intrinsic Pontine gliomas. Child’s Nervous System: ChNS. 2015;31(10):1773-1780. https://doi.org/10.1007/s00381-015-2832-1
  10. Rajshekhar V, Moorthy RK. Status of stereotactic biopsy in children with brain stem masses: insights from a series of 106 patients. Stereotactic and Functional Neurosurgery. 2010;88(6):360-366.  https://doi.org/10.1159/000319044
  11. Hamisch C, Kickingereder P, Fischer M, Simon T, Ruge MI. Update on the diagnostic value and safety of stereotactic biopsy for pediatric brainstem tumors: a systematic review and meta-analysis of 735 cases. Journal of Neurosurgery. Pediatrics. 2017;20(3):261-268.  https://doi.org/10.3171/2017.2.PEDS1665
  12. Carai A, Mastronuzzi A, De Benedictis A, Messina R, Cacchione A, Miele E, Randi F, Esposito G, Trezza A, Colafati GS, Savioli A, Locatelli F, Marras CE. Robot-Assisted Stereotactic Biopsy of Diffuse Intrinsic Pontine Glioma: A Single-Center Experience. World Neurosurgery. 2017;101:584-588.  https://doi.org/10.1016/j.wneu.2017.02.088
  13. Kickingereder P, Willeit P, Simon T, Ruge MI. Diagnostic value and safety of stereotactic biopsy for brainstem tumors: a systematic review and meta-analysis of 1480 cases. Neurosurgery. 2013;72(6):873-882.  https://doi.org/10.1227/NEU.0b013e31828bf445.
  14. Azad TD, Jin MC, Bernhardt LJ, Bettegowda C. Liquid biopsy for pediatric diffuse midline glioma: a review of circulating tumor DNA and cerebrospinal fluid tumor DNA. Neurosurgical Focus. 2020;48(1):E9.  https://doi.org/10.3171/2019.9.FOCUS19699
  15. Shcherbenko OI, Kumirova EV, Regentova OS. «Liquid biopsy» for brain tumors: state of problem. Rossijskij zhurnal detskoj gematologii i onkologii. 2019;6(2):61-67. (In Russ.). https://doi.org/10.21682/2311-1267-2019-6-2-61-67
  16. Lu VM, Power EA, Zhang L, Daniels DJ. Liquid biopsy for diffuse intrinsic pontine glioma: an update. Journal of Neurosurgery. Pediatrics. 2019 Sep 6;1-8.  https://doi.org/10.3171/2019.6.PEDS19259.
  17. Jansen MH, van Vuurden DG, Vandertop WP, Kaspers GJ. Diffuse intrinsic pontine gliomas: a systematic update on clinical trials and biology. Cancer Treatment Reviews. 2012;38(1):27-35.  https://doi.org/10.1016/j.ctrv.2011.06.007
  18. Buczkowicz P, Bartels U, Bouffet E, Becher O, Hawkins C. Histopathological spectrum of paediatric diffuse intrinsic pontine glioma: diagnostic and therapeutic implications. Acta Neuropathologica. 2014;128(4):573-581.  https://doi.org/10.1007/s00401-014-1319-6
  19. Buczkowicz P, Hawkins C. Pathology, Molecular Genetics, and Epigenetics of Diffuse Intrinsic Pontine Glioma. Frontiers in Oncology 2015;5:147.  https://doi.org/10.3389/fonc.2015.00147
  20. Hennika T, Becher OJ. Diffuse Intrinsic Pontine Glioma: Time for Cautious Optimism. Journal of Child Neurology. 2016;31(12):1377-1385. https://doi.org/10.1177/0883073815601495
  21. Mackay A, Burford A, Carvalho D, Izquierdo E, Fazal-Salom J, Taylor KR, Bjerke L, Clarke M, Vinci M, Nandhabalan M, Temelso S, Popov S, Molinari V, Raman P, Waanders AJ, Han HJ, Gupta S, Marshall L, Zacharoulis S, Vaidya S, Mandeville HC, Bridges LR, Martin AJ, Al-Sarraj S, Chandler C, Ng HK, Li X, Mu K, Trabelsi S, Brahim DH, Kisljakov AN, Konovalov DM, Moore AS, Carcaboso AM, Sunol M, de Torres C, Cruz O, Mora J, Shats LI, Stavale JN, Bidinotto LT, Reis RM, Entz-Werle N, Farrell M, Cryan J, Crimmins D, Caird J, Pears J, Monje M, Debily MA, Castel D, Grill J, Hawkins C, Nikbakht H, Jabado N, Baker SJ, Pfister SM, Jones DTW, Fouladi M, von Bueren AO, Baudis M, Resnick A, Jones C. Integrated Molecular Meta-Analysis of 1,000 Pediatric High-Grade and Diffuse Intrinsic Pontine Glioma. Cancer Cell. 2017;32(4):520-537.e5.  https://doi.org/10.1016/j.ccell.2017.08.017
  22. WHO Classification of Tumours of the Central Nervous System, Revised. Fourth Edition International Agency for Research on Cancer, Lyon; 2016;57-59. 
  23. Castel D, Philippe C, Calmon R, Le Dret L, Truffaux N, Boddaert N, Pagès M, Taylor KR, Saulnier P, Lacroix L, Mackay A, Jones C, Sainte-Rose C, Blauwblomme T, Andreiuolo F, Puget S, Grill J, Varlet P, Debily MA. Histone H3F3A and HIST1H3B K27M mutations define two subgroups of diffuse intrinsic pontine gliomas with different prognosis and phenotypes. Acta Neuropathologica. 2015;130(6):815-827.  https://doi.org/10.1007/s00401-015-1478-0
  24. Lassaletta A, Zapotocky M, Mistry M, Ramaswamy V, Honnorat M, Krishnatry R, Guerreiro Stucklin A, Zhukova N, Arnoldo A, Ryall S, Ling C, McKeown T, Loukides J, Cruz O, de Torres C, Ho CY, Packer RJ, Tatevossian R, Qaddoumi I, Harreld JH, Dalton JD, Mulcahy-Levy J, Foreman N, Karajannis MA, Wang S, Snuderl M, Nageswara Rao A, Giannini C, Kieran M, Ligon KL, Garre ML, Nozza P, Mascelli S, Raso A, Mueller S, Nicolaides T, Silva K, Perbet R, Vasiljevic A, Faure Conter C, Frappaz D, Leary S, Crane C, Chan A, Ng HK, Shi ZF, Mao Y, Finch E, Eisenstat D, Wilson B, Carret AS, Hauser P, Sumerauer D, Krskova L, Larouche V, Fleming A, Zelcer S, Jabado N, Rutka JT, Dirks P, Taylor MD, Chen S, Bartels U, Huang A, Ellison DW, Bouffet E, Hawkins C, Tabori U. Therapeutic and Prognostic Implications of BRAF V600E in Pediatric Low-Grade Gliomas. Journal of Clinical Oncology. 2017;35(25):2934-2941. https://doi.org/10.1200/JCO.2016.71.8726
  25. Solomon DA, Wood MD, Tihan T, Bollen AW, Gupta N, Phillips JJ, Perry A. Diffuse Midline Gliomas with Histone H3-K27M Mutation: A Series of 47 Cases Assessing the Spectrum of Morphologic Variation and Associated Genetic Alterations. Brain Pathology. 2016;26(5):569-580.  https://doi.org/10.1111/bpa.12336
  26. Hoffman LM, Veldhuijzen van Zanten SEM, Colditz N, Baugh J, Chaney B, Hoffmann M, Lane A, Fuller C, Miles L, Hawkins C, Bartels U, Bouffet E, Goldman S, Leary S, Foreman NK, Packer R, Warren KE, Broniscer A, Kieran MW, Minturn J, Comito M, Broxson E, Shih CS, Khatua S, Chintagumpala M, Carret AS, Escorza NY, Hassall T, Ziegler DS, Gottardo N, Dholaria H, Doughman R, Benesch M, Drissi R, Nazarian J, Jabado N, Boddaert N, Varlet P, Giraud G, Castel D, Puget S, Jones C, Hulleman E, Modena P, Giagnacovo M, Antonelli M, Pietsch T, Gielen GH, Jones DTW, Sturm D, Pfister SM, Gerber NU, Grotzer MA, Pfaff E, von Bueren AO, Hargrave D, Solanki GA, Jadrijevic Cvrlje F, Kaspers GJL, Vandertop WP, Grill J, Bailey S, Biassoni V, Massimino M, Calmon R, Sanchez E, Bison B, Warmuth-Metz M, Leach J, Jones B, van Vuurden DG, Kramm CM, Fouladi M. Clinical, Radiologic, Pathologic, and Molecular Characteristics of Long-Term Survivors of Diffuse Intrinsic Pontine Glioma (DIPG): A Collaborative Report From the International and European Society for Pediatric Oncology DIPG Registries. Journal of Clinical Oncology. 2018;36(19):1963-1972. https://doi.org/10.1200/JCO.2017.75.9308
  27. Gallitto M, Lazarev S, Wasserman I, Stafford JM, Wolden SL, Terezakis SA, Bindra RS, Bakst RL. Role of Radiation Therapy in the Management of Diffuse Intrinsic Pontine Glioma: A Systematic Review. Advances in Radiation Oncology. 2019;4(3):520-531.  https://doi.org/10.1016/j.adro.2019.03.009
  28. Muroi A, Mizumoto M, Ishikawa E, Ihara S, Fukushima H, Tsurubuchi T, Sakurai H, Matsumura A. Proton therapy for newly diagnosed pediatric diffuse intrinsic pontine glioma. Child’s Nervous System: ChNS. 2020;36(3):507-512.  https://doi.org/10.1007/s00381-019-04420-9
  29. Janssens GO, Gandola L, Bolle S, Mandeville H, Ramos-Albiac M, van Beek K, Benghiat H, Hoeben B, Morales La Madrid A, Kortmann RD, Hargrave D, Menten J, Pecori E, Biassoni V, von Bueren AO, van Vuurden DG, Massimino M, Sturm D, Peters M, Kramm CM. Survival benefit for patients with diffuse intrinsic pontine glioma (DIPG) undergoing re-irradiation at first progression: A matched-cohort analysis on behalf of the SIOP-E-HGG/DIPG working group. European Journal of Cancer. 2017;73:38-47.  https://doi.org/10.1016/j.ejca.2016.12.007
  30. Shcherbenko OI. Reirradiation treatment of diffuse brain tem tumors in children. Vestnik Rossiyskogo nauchnogo centra rentgenoradiologii. 2013;4(13):1-9. (In Russ.).
  31. Levin VA, Edwards MS, Wara WM, Allen J, Ortega J, Vestnys P. 5-Fluorouracil and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) followed by hydroxyurea, misonidazole, and irradiation for brain stem gliomas: a pilot study of the Brain Tumor Research Center and the Childrens Cancer Group. Neurosurgery. 1984;14(6):679-681.  https://doi.org/10.1227/00006123-198406000-00006
  32. Wakabayashi T, Yoshida J, Mizuno M, Kito A, Sugita K. Effectiveness of interferon-beta, ACNU, and radiation therapy in pediatric patients with brainstem glioma. Neurologia Medico-Chirurgica. 1992;32(13):942-946.  https://doi.org/10.2176/nmc.32.942
  33. Kretschmar CS, Tarbell NJ, Barnes PD, Krischer JP, Burger PC, Kun L. Pre-irradiation chemotherapy and hyperfractionated radiation therapy 66 Gy for children with brain stem tumors. A phase II study of the Pediatric Oncology Group, Protocol 8833. Cancer. 1993;72(4):1404-1413. https://doi.org/10.1002/1097-0142(19930815)72:4<1404::aid-cncr2820720441>3.0.co;2-g "> 3.0.co;2-g" target="_blank">https://doi.org/10.1002/1097-0142(19930815)72:4<1404::aid-cncr2820720441>3.0.co;2-g
  34. Dunkel IJ, Garvin JH Jr, Goldman S, Ettinger LJ, Kaplan AM, Cairo M, Li H, Boyett JM, Finlay JL. High dose chemotherapy with autologous bone marrow rescue for children with diffuse pontine brain stem tumors. Children’s Cancer Group. Journal of Neuro-Oncology. 1998;37(1):67-73.  https://doi.org/10.1023/a:1005874508975
  35. Allen J, Siffert J, Donahue B, Nirenberg A, Jakacki R, Robertson P, DaRosso R, Thoron L, Rosovsky M, Pinto R. A phase I/II study of carboplatin combined with hyperfractionated radiotherapy for brainstem gliomas. Cancer. 1999;86(6):1064-1069. https://doi.org/10.1002/(sici)1097-0142(19990915)86:6<1064::aid-cncr24>3.0.co;2-1 "> 3.0.co;2-1" target="_blank">https://doi.org/10.1002/(sici)1097-0142(19990915)86:6<1064::aid-cncr24>3.0.co;2-1
  36. Freeman CR, Kepner J, Kun LE, Sanford RA, Kadota R, Mandell L, Friedman H. A detrimental effect of a combined chemotherapy-radiotherapy approach in children with diffuse intrinsic brain stem gliomas? International Journal of Radiation Oncology, Biology, Physics. 2000;47(3):561-564.  https://doi.org/10.1016/S0360-3016(00)00471-5
  37. Bouffet E, Raquin M, Doz F, Gentet JC, Rodary C, Demeocq F, Chastagner P, Lutz P, Hartmann O, Kalifa C. Radiotherapy followed by high dose busulfan and thiotepa: a prospective assessment of high dose chemotherapy in children with diffuse pontine gliomas. Cancer. 2000;88(3):685-692. https://doi.org/10.1002/(sici)1097-0142(20000201)88:3<685::aid-cncr27>3.0.co;2-k "> 3.0.co;2-k" target="_blank">https://doi.org/10.1002/(sici)1097-0142(20000201)88:3<685::aid-cncr27>3.0.co;2-k
  38. Broniscer A, Leite CC, Lanchote VL, Machado TM, Cristófani LM. Radiation therapy and high-dose tamoxifen in the treatment of patients with diffuse brainstem gliomas: results of a Brazilian cooperative study. Brainstem Glioma Cooperative Group. Journal of Clinical Oncology. 2000;18(6):1246-1253. https://doi.org/10.1200/JCO.2000.18.6.1246
  39. Jennings MT, Sposto R, Boyett JM, Vezina LG, Holmes E, Berger MS, Bruggers CS, Bruner JM, Chan KW, Dusenbery KE, Ettinger LJ, Fitz CR, Lafond D, Mandelbaum DE, Massey V, McGuire W, McNeely L, Moulton T, Pollack IF, Shen V. Preradiation Chemotherapy in Primary High-Risk Brainstem Tumors: Phase II Study CCG-9941 of the Children’s Cancer Group. Journal of Clinical Oncology. 2002;20(16):3431-3437. https://doi.org/10.1200/JCO.2002.04.109
  40. Doz F, Neuenschwander S, Bouffet E, Gentet JC, Schneider P, Kalifa C, Mechinaud F, Chastagner P, De Lumley L, Sariban E, Plantaz D, Mosseri V, Bours D, Alapetite C, Zucker JM. Carboplatin before and during radiation therapy for the treatment of malignant brain stem tumours: a study by the Société Française d’Oncologie Pédiatrique. European Journal of Cancer. 2002;38(6):815-819.  https://doi.org/10.1016/S0959-8049(02)00029-1
  41. Wolff JE, Kortmann RD, Wolff B, Pietsch T, Peters O, Schmid HJ, Rutkowski S, Warmuth-Metz M, Kramm C. High dose methotrexate for pediatric high grade glioma: results of the HIT-GBM-D Pilot study. Journal of Neuro-Oncology. 2011;102(3):433-442.  https://doi.org/10.1007/s11060-010-0334-2
  42. Marcus KJ, Dutton SC, Barnes P, Coleman CN, Pomeroy SL, Goumnerova L, Billett AL, Kieran M, Tarbell NJ. A phase I trial of etanidazole and hyperfractionated radiotherapy in children with diffuse brainstem glioma. International Journal of Radiation Oncology, Biology, Physics. 2003;55(5):1182-1185. https://doi.org/10.1016/S0360-3016(02)04391-2
  43. Sanghavi SN, Needle MN, Krailo MD, Geyer JR, Ater J, Mehta MP. A phase I study of topotecan as a radiosensitizer for brainstem glioma ofchildhood: First report of the Children’s Cancer Group-0952. Neuro-Oncology. 2003;5(1):8-13.  https://doi.org/10.1093/neuonc/5.1.8
  44. Bernier-Chastagner V, Grill J, Doz F, Bracard S, Gentet JC, Marie-Cardine A, Luporsi E, Margueritte G, Lejars O, Laithier V, Mechinaud F, Millot F, Kalifa C, Chastagner P. Topotecan as a radiosensitizer in the treatment of children with malignant diffuse brainstem gliomas: Results of a French Society of Paediatric Oncology Phase II Study. Cancer. 2005;104(12):2792-2797. https://doi.org/10.1002/cncr.21534
  45. Packer RJ, Krailo M, Mehta M, Warren K, Allen J, Jakacki R, Villablanca JG, Chiba A, Reaman G. Phase 1 study of concurrent RMP-7 and carboplatin with radiotherapy for children with newly diagnosed brainstem gliomas. Cancer. 2005;104(6):1281-1287. https://doi.org/10.1002/cncr.21301
  46. Greenberg ML, Fisher PG, Freeman C, Korones DN, Bernstein M, Friedman H, Blaney S, Hershon L, Zhou T, Chen Z, Kretschmar C. Etoposide, vincristine, and cyclosporin A with standard-dose radiation therapy in newly diagnosed diffuse intrinsic brainstem gliomas: A pediatric oncology group phase I study. Pediatric Blood & Cancer. 2005;45(5):644-648.  https://doi.org/10.1002/pbc.20382
  47. Wolff JE, Wagner S, Reinert C, Gnekow A, Kortmann RD, Kühl J, Van Gool SW. Maintenance treatment with interferon-gamma and low-dose cyclophosphamide for pediatric high-grade glioma. Journal of Neuro-Oncology. 2006;79(3):315-321.  https://doi.org/10.1007/s11060-006-9147-8
  48. Warren K, Jakacki R, Widemann B, Aikin A, Libucha M, Packer R, Vezina G, Reaman G, Shaw D, Krailo M, Osborne C, Cehelsky J, Caldwell D, Stanwood J, Steinberg SM, Balis FM. Phase II trial of intravenous lobradimil and carboplatin in childhood brain tumors: a report from the Children’s Oncology Group. Cancer Chemotherapy and Pharmacology. 2006;58(3):343-347.  https://doi.org/10.1007/s00280-005-0172-7
  49. Turner CD, Chi S, Marcus KJ, MacDonald T, Packer RJ, Poussaint TY, Vajapeyam S, Ullrich N, Goumnerova LC, Scott RM, Briody C, Chordas C, Zimmerman MA, Kieran MW. Phase II study of thalidomide and radiation in children with newly diagnosed brain stem gliomas and glioblastoma multiforme. Journal of Neuro-Oncology. 2007;82(1):95-101.  https://doi.org/10.1007/s11060-006-9251-9
  50. Frappaz D, Schell M, Thiesse P, Marec-Bérard P, Mottolese C, Perol D, Bergeron C, Philip T, Ricci AC, Galand-Desme S, Szathmari A, Carrie C. Preradiation chemotherapy may improve survival in pediatric diffuse intrinsic brainstem gliomas: Final results of BSG 98 prospective trial. Neuro-Oncology. 2008;10(4):599-607.  https://doi.org/10.1215/15228517-2008-029
  51. Massimino M, Spreafico F, Biassoni V, Simonetti F, Riva D, Trecate G, Giombini S, Poggi G, Pecori E, Pignoli E, Casanova M, Ferrari A, Meazza C, Luksch R, Terenziani M, Cefalo G, Podda M, Polastri D, Clerici CA, Fossati-Bellani F, Gandola L. Diffuse pontine gliomas in children: changing strategies, changing results? A mono-institutional 20-year experience. Journal of Neuro-Oncology. 2008;87(3):355-361.  https://doi.org/10.1007/s11060-008-9525-5
  52. Korones DN, Fisher PG, Kretschmar C, Zhou T, Chen Z, Kepner J, Freeman C. Treatment of children with diffuse intrinsic brain stem glioma with radiotherapy, vincristine and oral VP-16: A Children’s Oncology Group phase II study. Pediatric Blood and Cancer. 2008;50(2):227-230.  https://doi.org/10.1002/pbc.21154
  53. Michalski A, Bouffet E, Taylor RE, Hargrave D, Walker D, Picton S, Robinson K, Pizer B, Bujkiewicz S. The addition of high-dose tamoxifen to standard radiotherapy does not improve the survival of patients with diffuse intrinsic pontine glioma. Journal of Neuro-Oncology. 2010;100(1):81-88.  https://doi.org/10.1007/s11060-010-0141-9
  54. Grundy RG, Wilne SH, Robinson KJ, Ironside JW, Cox T, Chong WK, Michalski A, Campbell RH, Bailey CC, Thorp N, Pizer B, Punt J, Walker DA, Ellison DW, Machin D; Children’s Cancer and Leukaemia Group (formerly UKCCSG) Brain Tumour Committee. Primary postoperative chemotherapy without radiotherapy for treatment of brain tumours other than ependymoma in children under 3 years: Results of the first UKCCSG/SIOP CNS 9204 trial. European Journal of Cancer. 2010;46(1):120-133.  https://doi.org/10.1016/j.ejca.2009.09.013
  55. Wolff JE, Driever PH, Erdlenbruch B, Kortmann RD, Rutkowski S, Pietsch T, Parker C, Metz MW, Gnekow A, Kramm CM. Intensive chemotherapy improves survival in pediatric high-grade glioma after gross total resection: results of the HIT-GBM-C protocol. Cancer. 2010;116(3):705-712.  https://doi.org/10.1002/cncr.24730
  56. Shcherbenko OI, Parkhomenko RA, Zelinskaya NI, Antonenko FF. Radiation and chemoradiation therapy of the diffuse growing brain stem tumors in children: does adjuvant chemotherapy effect on the results? Onkopediatria. 2015;2(3):188-192. (In Russ.). https://doi.org/10.15690/onco.v2.i3.1396
  57. Fleischhack G, Massimino M, Warmuth-Metz M, Khuhlaeva E, Janssen G, Graf N, Rutkowski S, Beilken A, Schmid I, Biassoni V, Gorelishev SK, Kramm C, Reinhard H, Schlegel PG, Kortmann RD, Reuter D, Bach F, Iznaga-Escobar NE, Bode U. Nimotuzumab and radiotherapy for treatment of newly diagnosed diffuse intrinsic pontine glioma (DIPG): a phase III clinical study. Journal of Neuro-Oncology. 2019;143(1):107-113.  https://doi.org/10.1007/s11060-019-03140-z
  58. Geoerger B, Hargrave D, Thomas F, Ndiaye A, Frappaz D, Andreiuolo F, Varlet P, Aerts I, Riccardi R, Jaspan T, Chatelut E, Le Deley MC, Paoletti X, Saint-Rose C, Leblond P, Morland B, Gentet JC, Méresse V, Vassal G; ITCC (Innovative Therapies for Children with Cancer) European Consortium. Innovative Therapies for Children with Cancer) European Consortium, Innovative Therapies for Children with Cancer pediatric phase I study of erlotinib in brainstem glioma and relapsing/refractory brain tumors. Neuro-Oncology. 2011;13(1):109-118.  https://doi.org/10.1093/neuonc/noq141
  59. Pollack IF, Stewart CF, Kocak M, Poussaint TY, Broniscer A, Banerjee A, Douglas JG, Kun LE, Boyett JM, Geyer JR. A phase II study of gefitinib and irradiation in children with newly diagnosed brainstem gliomas: a report from the Pediatric Brain Tumor Consortium. Neuro-Oncology. 2011;13(3):290-297.  https://doi.org/10.1093/neuonc/noq199
  60. Geyer JR, Stewart CF, Kocak M, Broniscer A, Phillips P, Douglas JG, Blaney SM, Packer RJ, Gururangan S, Banerjee A, Kieran MW, Kun LE, Gilbertson RJ, Boyett JM. A phase I and biology study of gefitinib and radiation in children with newly diagnosed brain stem gliomas or supratentorial malignant gliomas. European Journal of Cancer. 2010;46(18):3287-3293. https://doi.org/10.1016/j.ejca.2010.07.005
  61. Bartels U, Wolff J, Gore L, Dunkel I, Gilheeney S, Allen J, Goldman S, Yalon M, Packer RJ, Korones DN, Smith A, Cohen K, Kuttesch J, Strother D, Baruchel S, Gammon J, Kowalski M, Bouffet E. Phase 2 study of safety and efficacy of nimotuzumab in pediatric patients with progressive diffuse intrinsic pontine glioma. Neuro-Oncology. 2014;16(11):1554-1559. https://doi.org/10.1093/neuonc/nou091
  62. Broniscer A, Baker JN, Tagen M, Onar-Thomas A, Gilbertson RJ, Davidoff AM, Pai Panandiker AS, Leung W, Chin TK, Stewart CF, Kocak M, Rowland C, Merchant TE, Kaste SC, Gajjar A. Phase I study of vandetanib during and after radiotherapy in children with diffuse intrinsic pontine glioma. Journal of Clinical Oncology. 2010;28(31):4762-4768. https://doi.org/10.1200/JCO.2010.30.3545
  63. Pollack IF, Jakacki RI, Blaney SM, Hancock ML, Kieran MW, Phillips P, Kun LE, Friedman H, Packer R, Banerjee A, Geyer JR, Goldman S, Poussaint TY, Krasin MJ, Wang Y, Hayes M, Murgo A, Weiner S, Boyett JM. Phase I trial of imatinib in children with newly diagnosed brainstem and recurrent malignant gliomas: a Pediatric Brain Tumor Consortium report. Neuro-Oncology. 2007;9(2):145-160.  https://doi.org/10.1215/15228517-2006-031
  64. Gururangan S, Chi SN, Young Poussaint T, Onar-Thomas A, Gilbertson RJ, Vajapeyam S, Friedman HS, Packer RJ, Rood BN, Boyett JM, Kun LE. Lack of efficacy of bevacizumab plus irinotecan in children with recurrent malignant glioma and diffuse brainstem glioma: a Pediatric Brain Tumor Consortium study. Journal of Clinical Oncology. 2010;28(18):3069-3075. https://doi.org/10.1200/JCO.2009.26.8789
  65. Salloum R, DeWire M, Lane A, Goldman S, Hummel T, Chow L, Miles L, Sutton M, Stevenson C, Fouladi M, Leach J. Patterns of progression in pediatric patients with high-grade glioma or diffuse intrinsic pontine glioma treated with Bevacizumab-based therapy at diagnosis. Journal of Neuro-Oncology. 2015;121(3):591-598.  https://doi.org/10.1007/s11060-014-1671-3
  66. Geoerger B, Kieran MW, Grupp S, Perek D, Clancy J, Krygowski M, Ananthakrishnan R, Boni JP, Berkenblit A, Spunt SL. Phase II trial of temsirolimus in children with high-grade glioma, neuroblastoma and rhabdomyosarcoma. European Journal of Cancer. 2012;48(2):253-262.  https://doi.org/10.1016/j.ejca.2011.09.021
  67. Haas-Kogan DA, Banerjee A, Poussaint TY, Kocak M, Prados MD, Geyer JR, Fouladi M, Broniscer A, Minturn JE, Pollack IF, Packer RJ, Boyett JM, Kun LE. Phase II trial of tipifarnib and radiation in children with newly diagnosed diffuse intrinsic pontine gliomas. Neuro-Oncology. 2011;13(3):298-306.  https://doi.org/10.1093/neuonc/noq202
  68. Felix FH, de Araujo OL, da Trindade KM, Trompieri NM, Fontenele JB. Retrospective evaluation of the outcomes of children with diffuse intrinsic pontine glioma treated with radiochemotherapy and valproic acid in a single center. Journal of Neuro-Oncology. 2014;116(2):261-266.  https://doi.org/10.1007/s11060-013-1280-6
  69. Rechberger JS, Lu VM, Zhang L, Power EA, Daniels DJ. Clinical trials for diffuse intrinsic pontine glioma: the current state of affairs. Child’s Nervous System: ChNS. 2020;36(1):39-46.  https://doi.org/10.1007/s00381-019-04363-1
  70. Clymer J, Kieran MW. The Integration of Biology into the Treatment of Diffuse Intrinsic Pontine Glioma: A Review of the North American Clinical Trial Perspective. Frontiers in Oncology. 2018;8:169.  https://doi.org/10.3389/fonc.2018.00169
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.